AAAP is offering two new advanced courses in 2018 for health professionals who want to expand their expertise and clinical practices to address the opioid crisis. Both will be held prior to the start of the 29th Annual Meeting and Scientific Symposium.

Click on the course you would like additional information:
Practical Guide to Offering Office-Based Opioid Treatment
Advanced Addiction Psychopharmacology Course


Practical Guide to Offering Office-Based Opioid Treatment

StethoscopeWednesday, December 5, 2018, 3:00 pm – 7:30 pm

Where:
Hyatt Regency Coconut Point Resort and Spa, Bonita Springs, FL

Cost:
$275 AAAP members
$325 Non-members

Presenter Financial Disclosure Information – Coming Soon
Course Schedule (Subject to change)

Register Now

Who Should Attend?

This intensive 4.5-hour course is designed for psychiatrists, physicians (MD/DO), nurse practitioners (NP) and physician assistants (PA), dentists, and pharmacists who have taken the medication assisted treatment (MAT) waiver course but would like to expand your expertise and comfort level in treating patients with SUD.

The course will give an overview of treating opioid use disorder with buprenorphine and injectable naltrexone from experts in the field of addiction.

This Advanced Course will be held simultaneously to AAAP’s Addictions and Their Treatment course prior to AAAP’s Annual Meeting.

Participants will be provided with a Resource Kit (printed copy and e-link) to improve their practice. It will contain helpful information and resources for clinicians to utilize in their practice and share and discuss with their colleagues and with their patients.

Accreditation Statement

American Academy of Addiction Psychiatry is accredited by ACCME to provide continuing medical education for physicians.

Designation Statement

American Academy of Addiction Psychiatry designates this live activity for a maximum of 4.5 (four and one-half) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Educational Objectives

At the completion of this course, participants will be able to:

  1. Describe various models of care used to implement medication treatment for the treatment of opioid use disorders
  2. Apply strategies involved in minimizing diversion of controlled medications as well as tapering strategies
  3. Describe approaches to managing acute and chronic pain

Advanced Addiction Psychopharmacology Course

PhysicianWednesday, December 5, 2018, 8:00 am – 5:15 pm
Thursday, December 6, 2018, 8:00 am – 12:15 pm

Where:
Hyatt Regency Coconut Point Resort and Spa, Bonita Springs, FL

Cost:
$450 AAAP members
$500 Non-members

Presenter Financial Disclosure Information – Coming Soon
Course Schedule (Subject to change)

Register Now

Who Should Attend?

This two-day course is designed for clinicians with a foundation in addictions but would like more experience in treating with medications. The Advanced Addiction Psychopharmacology Course will be approached as a case-based workshop.

This Advanced Course will be held simultaneously to AAAP’s Addictions and Their Treatment course prior to AAAP’s Annual Meeting. Please note that there is a slight overlap with the meeting.

Accreditation Statement

American Academy of Addiction Psychiatry is accredited by ACCME to provide continuing medical education for physicians.

Designation Statement

American Academy of Addiction Psychiatry designates this live activity for a maximum of 12 (twelve) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Educational Objectives

This course is designed for learners with a foundational knowledge of addiction psychiatry. Learners who attend this activity will receive a more in-depth educational experience in addiction psychopharmacology.

After participating in this course, learners should be able to:

  • Describe how to use methadone, buprenorphine and naltrexone in clinical practice for the treatment of opioid use disorders.
  • Describe medication treatments for alcohol use disorders.
  • Determine when to use varenicline, bupropion, and nicotine replacement therapy (NRT) for treatment of nicotine use disorders.
  • Discuss new evidence-based medication treatments for cocaine and methamphetamine use disorder.
  • Discuss new evidence-based medication treatments for cannabis use disorder.
  • Discuss medication approaches for the treatment of sedative-hypnotic use disorder.
  • List evidence-based options for anti-depressant and anti-anxiety pharmacotherapy when treating patients with a co-occurring substance use disorder.
  • Discuss evidence-based pharmacotherapy for treatment of ADHD with co-occurring substance use disorders.
  • Discuss the pharmacotherapy of bipolar disorder in patients with co-occurring substance use disorder.